Oxygenta Pharmaceutical financial results announcements

Financial ResultsOxygenta Pharmaceutical Ltd SSORGS

Oxygenta Pharmaceutical Q1 FY27 Results: Net Loss of ₹2.1 Cr, Loss Narrows

Oxygenta Pharmaceutical Ltd reported revenue from operations of ₹37 Cr (+145.0% YoY) and a net loss of ₹2.1 Cr for Q1 FY27.

Key figure

Net loss ₹2.1 Cr

Financial ResultsOxygenta Pharmaceutical Ltd SSORGS

Oxygenta Pharmaceutical Q4 FY26 Results: Net Loss of ₹1.7 Cr, Loss Narrows

Oxygenta Pharmaceutical Ltd reported revenue from operations of ₹49.6 Cr (+0.2% YoY) and a net loss of ₹1.7 Cr for Q4 FY26.

Key figure

Net loss ₹1.7 Cr

Financial ResultsOxygenta Pharmaceutical Ltd SSORGS

Oxygenta Pharmaceutical Financial Results

Oxygenta Pharmaceutical Limited reported its audited financial results for the year ended March 31, 2026. The company also announced key board appointments and auditor changes.